MTDH and breast carcinoma: It is also found that genetic alteration or gene amplification of metastasis gene metadherin (MTDH) is associated with more than 40% breast cancer cases with poor clinical outcomes.93 These findings establish that anticancer drugs targeting ABC transporters and MTDH can be used in increasing the chemotherapeutic efficacy and reducing metastasis risk.